Pharmacological management of postoperative ileus

Canadian Journal of Surgery

Volumn 52, Issue 2, 2009, Pages 153-157

  Zeinali, Farhad ^a   Stulberg, Jonah J ^a   Delaney, Conor P ^a,b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Division of Colorectal Surgery

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALVIMOPAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISACODYL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; DIHYDROERGOTAMINE; LAXATIVE; MU OPIATE RECEPTOR; NALTREXONE; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERIDINE DERIVATIVE; PROPRANOLOL; QUATERNARY AMMONIUM DERIVATIVE; SEROTONIN AGONIST;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; HUMAN; ILEUS; INFLAMMATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BISACODYL; CATHARTICS; CISAPRIDE; DIHYDROERGOTAMINE; HUMANS; ILEUS; INFLAMMATION; NALTREXONE; NEOSTIGMINE; PARASYMPATHOMIMETICS; PIPERIDINES; POSTOPERATIVE COMPLICATIONS; PROPRANOLOL; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, OPIOID, MU; SEROTONIN RECEPTOR AGONISTS;

EID: 67249107670     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Delaney C, Kehlet H, Senagore A, et al. Postoperative ileus: profiles, risk factors, and definitions-a framework for optimizing surgical outcomes in patients undergoing major abdominal colorectal surgery. In: Bosker G, editor. Clinical comensus update in general surgery. Roswell (GA): Pharmatecture, LLC); 2006. Available: www.clinicalwebcasts.com/pdfs/GenSurg-WEB.pdf (accessed 2008 May 15).
2. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg 2000;87:1480-1493
3. 3. Delaney CP, Zutshi M, Senagore AJ, et al. Prospective randomized controlled trial between a padiway of Controlled Rehabilitation with Early Ambulation and Diet (CREAD) and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003;46:851-859 (Pubitemid 36875478)
4. 4. Mattei P, Romgeau JL. Review of the padiophysiology and management of postoperative ileus. World J Surg 2006;30:1382-1391 (Pubitemid 44421237)
5. 5. Delaney CP. Clinical perspective on postoperative ileus and the effect of opiates. Neur-ogastroenter-ol Motil 2004;16(Supp1 2):1-4. (Pubitemid 39468868)
6. 6. Delaney CP, Fazio VW, Senagore AJ, et al. Fast-track post-operative management protocol for patients with high comorbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg 2001;88: 1533-1538 (Pubitemid 32989477)
7. 7. Kehlet H, Holte K. Multimodal strategies to improve surgical outcome. Am J Surg 2002;183:630-641 (Pubitemid 34722528)
8. 8. Holte K, Kehlet H. Postoperative ileus: progress towards effective management. Drugs 2002;62:2603-2615 (Pubitemid 36098990)
9. Luckey A, Livingston E, Tache Y. Mechanisms and treatment of postoperative ileus. Arch Surg 2003;138:206-214
10. 10. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004; 16(suppl 2): 54-60. (Pubitemid 39468867)
11. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu-opioid antagonist. Ann Surg 2004;240: 728-735
12. 12. Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg 2007;245:355-363 (Pubitemid 46673131)
13. 13.DelaneyCP,WeeseJL,HymanNH,etal.PhaseIIItrialofalvimopan,anovel, peripherallyacting,muopioidantagonist, forpostoperativeileusaftermajorabdominalsurgery.DisColonRectum2005;48: 1114-1125(Pubitemid40897854)
14. 14. Viscusi ER, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endose 2006;20:64-70. (Pubitemid 43097035)
15. Adolor Corporation and GlaxoSmithKline. Adolor and GlaxoSmithKline announce FDA approval of Entereg(R) (alvimopan) for the management of postoperative ileus (POI) [press release]. Available: http://phx.corporate-ir. net/phoenix.zhtml?c=120919&p =irol-newsArticle&t=Regular&id= 1148660& (accessed 2008 May 20).